Skip to content

AVANÇOS CLÍNICOS NO USO DE PSICODÉLICOS PARA TRANSTORNOS PSIQUIÁTRICOS: UMA REVISÃO INTEGRATIVA

Alberto Almeida, Carlos Paulo da Silva, Clara Guerzoni, Ederaldo Oliveira, Edis Rodrigues Junior, Guilherme Mesquita, Higor Ruan Rosa, Izabela Christina Magalhães Malta Dionisio, Janaina Luiza Thomé, Karine Luz, Kayra Batista, Suellen Borges, Tânia Martin Guilherme, V.D.R. Dias, Weveson Tavares

Revista fisio&terapia. August 15, 2024 DOI: 10.69849/revistaft/ni10202408151406 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Integrative review Peer reviewed
Topics Anxiety
Keywords Psychotherapist Context archaeology Clinical practice Nursing
Key findings Psychedelics show potential effectiveness for treating depression, PTSD, and anxiety compared to traditional treatments.

Abstract

This integrative review explores the use of psychedelics in psychiatry, focusing on their historical context, recent resurgence, and clinical efficacy in treating psychiatric disorders such as depression, PTSD, and anxiety. Initially, psychedelic therapies showed promise in the 1950s and 1970s but were diminished due to restrictive policies and stigma. However, a resurgence in clinical interest has been driven by new research and changing public perceptions, highlighting the potential effectiveness of psychedelics compared to traditional treatments, which are often ineffective or have significant side effects. The review discusses the mechanisms of action and neuroplasticity induced by psychedelics, integrative therapeutic approaches, and the associated risks and ethical challenges. The future of psychedelic therapies appears promising, with advancements in research and regulatory changes potentially expanding their clinical applications. The review concludes with a reflection on clinical practice implications and suggestions for future research areas.

Comparable studies

Other narrative reviews on anxiety, most cited first.

Explore topics